Serum Institute seeks DCGI approval for Covishield as booster dose
New Delhi, 1/12:Serum Institute of India has sought the drug regulator’s approval to administer Covishield as a booster dose, citing adequate stock of the vaccine in the country and the demand for a booster shot due to the emergence of Omicron coronavirus variant, official sources said. In an application to the Drugs Controller…
